Research & Development

鲁播放在线天天穞日日穞夜夜穞天天啪天天舔天天透y党报谈全面提高义务教育质量:一分部署 九分落实


  每一座城池都有一位城主,謝寧對砍掉城主腦袋這種事沒有多少興趣。   越是靠近武威郡,路上的商隊以及行人就多了起來。鲁播放在线   彩畫三人的目的終于達到了,就齊齊的把腦袋探出窗子沖戴著幕籬的雲音大叫。天天穞日日穞夜夜穞   看到這一幕,彩畫,綠衣她們就開始後悔來到這片窮地方了。   雲瑯收回了漁網,漁網里卻什麼都沒有。天天啪天天舔天天透y   父親的頭頂上永遠有一只肥碩的雞,只要伸伸脖子就能夠到,然而,大王對這只雞永遠都是不屑一顧的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo